C

CEREPHARMA (Public limited company)

BE 0834.075.086 Active ●Rue des Journaliers(GHI) 15, 7822 Ath

CEREPHARMA is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0834.075.086. It was founded on 25-02-2011. Its registered office is in Ath. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € 933 614 and a profit of € 91 805. These accounts report 6.3 full-time equivalents. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.

Information last updated on 21-10-2026.

Company information

Status
Active
Enterprise number
BE 0834.075.086
VAT registered
Yes
Founded
25-02-2011
Latest accounts
2025
Employees
6.3 FTE
Region
Wallonia
Establishments
1
Filing record
On time 4 of 4 years
Peppol e-invoicing
Registered
Registered office
Rue des Journaliers(GHI) 15, 7822 Ath
Main activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE activities
21209 Fabrication d'autres produits pharmaceutiques
20420 Fabrication de parfums et de produits pour la toilette
21100 Fabrication de produits pharmaceutiques de base
46460 Commerce de gros de produits pharmaceutiques et médicaux
47730 Commerce de détail de produits pharmaceutiques

Key figures of CEREPHARMA

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ 91 805+63 %€ 56 289-68 %€ 175 839+35 %€ 129 784
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 933 614+11 %€ 841 809+7 %€ 785 520+29 %€ 609 681
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 1 524 415-2 %€ 1 550 659+1 %€ 1 530 746-3 %€ 1 576 462
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ 572 300+33 %€ 430 346-10 %€ 477 868+7 %€ 445 710
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
6.3---

Financial estimate

Financial health grade A, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
4 mandates on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity nearby.

CompanyTown
BAXTER 7860 Lessines
Etablissements Electro-Mécaniques Léon Van Rie 7390 Quaregnon
Continental Slag Systems 7100 La Louvière
Bureau d'Etudes Carmon 7000 Mons
Phoenix Scientific Innovation 7500 Tournai
SOL B 7860 Lessines
EURODERM 7000 Mons
CORAIL 7090 Braine-le-Comte
Looking for more information about CEREPHARMA?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is CEREPHARMA still active? Yes. The Crossroads Bank for Enterprises lists CEREPHARMA as active.

What is the VAT number of CEREPHARMA? The VAT number of CEREPHARMA is BE 0834.075.086.

When was CEREPHARMA founded? CEREPHARMA was founded on 25-02-2011.

What is the address of CEREPHARMA? The current registered office of CEREPHARMA is Rue des Journaliers(GHI) 15, 7822 Ath.

When did CEREPHARMA last file annual accounts? The latest annual accounts of CEREPHARMA were filed on 27-08-2026.

Does CEREPHARMA file its annual accounts on time? Yes. CEREPHARMA filed its annual accounts within the legal deadline for each of its last 4 financial years.

How many employees does CEREPHARMA have? CEREPHARMA employs 6.3 full-time equivalents according to its most recent annual accounts.

Is CEREPHARMA financially healthy? Addrly gives CEREPHARMA a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is CEREPHARMA profitable? The annual accounts of CEREPHARMA for 2025 show a profit of € 91 805.

What is the equity of CEREPHARMA? The equity of CEREPHARMA was € 933 614 at the close of the 2025 financial year.

Who are the directors of CEREPHARMA? The annual accounts of CEREPHARMA record 4 mandates. The names, roles and dates are visible with a free account.

Can CEREPHARMA receive Peppol e-invoices? Yes. CEREPHARMA is registered on the Peppol network and can receive structured electronic invoices.

What does CEREPHARMA do? The main activity of CEREPHARMA is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.

Sources

How Addrly builds and refreshes this data